CONSOLIDATED STATEMENTS OF CASH FLOWS - USD ($) $ in Thousands	12 Months Ended
	Dec. 31, 2022	Dec. 31, 2021	Dec. 31, 2020
CASH FLOWS FROM OPERATING ACTIVITIES
Net loss	$ (138,560)	$ (93,981)	$ (106,780)
Adjustments to reconcile net loss to net cash used in operating activities:
Depreciation and amortization	9,456	5,477	3,718
Stock-based compensation	33,321	25,363	12,057
Deferred income taxes	0	(2,477)	0
Change in right-of-use asset	2,730	2,180	1,887
Interest expense	799	36	1,030
Amortization of debt issuance costs and debt discount	160	250	258
Change in fair value of warrant liabilities	(7,446)	(2,947)	48,440
Change in fair value of derivative liability	0	0	5,308
Gain on extinguishment of tranche right liability	0	0	(1,610)
Inventory write down	1,600	808	797
Provision for doubtful accounts	346	379	67
Loss from disposal of property and equipment	430	0	0
Changes in operating assets and liabilities:
Accounts receivable	(856)	(8,007)	(1,457)
Inventory	(13,684)	(3,440)	(3,146)
Prepaid expenses and other assets	(3,148)	350	(1,442)
Accounts payable	4,191	(2,442)	144
Accrued and other liabilities	3,196	9,060	(417)
Operating lease liability	(3,225)	(1,670)	(971)
Net cash used in operating activities	(110,690)	(71,061)	(42,117)
CASH FLOWS FROM INVESTING ACTIVITIES
Proceeds from sale of property & equipment	275	0	0
Purchases of property and equipment	(5,422)	(4,283)	(3,509)
Acquisition, net of cash acquired	0	(10,946)
Net cash used in investing activities	(5,147)	(15,229)	(3,509)
CASH FLOWS FROM FINANCING ACTIVITIES
Proceeds from the merger and private offering	0	291,442	0
Payment of offering costs	0	(26,620)	0
Repayment of debt	0	(7,000)	(3,000)
Proceeds from issuance of promissory notes to related parties	0	5,000	0
Repayment of promissory notes to related parties	0	(5,000)	0
Repurchase of common stock	(45)	(45)	0
Proceeds from exercise of stock options	470	526	1,337
Proceeds from ESPP purchase	378	0	0
Proceeds from exercise of warrants	0	1	0
Proceeds from issuance of redeemable convertible preferred stock, net off issuance cost of 265	0	0	41,526
Proceeds from borrowings, net of debt discount and issuance costs	39,077	0	0
Proceeds from the issuance of common stock under at-the-market offering, net of commissions and fees	16,322	0	0
Taxes paid related to net share settlement of restricted stock units	(59)	0	0
Net cash provided by financing activities	55,602	258,304	39,863
Effect of exchange rates on cash and cash equivalents	(143)	0	0
Net increase (decrease) in cash, cash equivalents and restricted cash	(60,378)	172,014	(5,763)
Cash, cash equivalents and restricted cash at beginning of period	184,656	12,642	18,405
Cash, cash equivalents and restricted cash at end of period	124,278	184,656	12,642
SUPPLEMENTAL DISCLOSURES OF OPERATING ACTIVITIES:
Cash paid for interest	1,735	635	1,228
SUPPLEMENTAL DISCLOSURES OF NON-CASH INVESTING AND FINANCING INFORMATION:
Property and equipment purchases included in accounts payable and accrued liabilities	269	377	232
Equity issued in connection with acquisition	0	61,105	0
Issuance of redeemable convertible preferred stock upon exercise of warrants	0	58,097	0
Conversion of redeemable convertible preferred stock to common stock	0	97,322	40,016
Right-of-use assets obtained in exchange for operating lease liability	571	6,265	6,409
Unpaid at-the-market offering costs	5	0	0
Common Stock
CASH FLOWS FROM FINANCING ACTIVITIES
At-the-market offering costs for the issuance of common stock	$ (541)	$ 0	$ 0